Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

Last updated: March 17, 2026
Sponsor: Yale University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Reproductive Health

Pregnancy

Contraception

Treatment

Generic Information

PrEP Decision Aid

Clinical Study ID

NCT06684613
2000038555
1R34MH137756-01
  • Ages > 18
  • Female
  • Accepts Healthy Volunteers

Study Summary

This study addresses the need for HIV prevention to be integrated into counseling visits at sexual and reproductive health clinics.

Eligibility Criteria

Inclusion

Patients (inclusion):

  • Woman

  • Aged 18 years or older

  • Have a uterus

  • Do not have HIV (by self-report)

  • Not currently on PrEP

  • Comfortable conversing in English or Spanish

  • Able to participate in informed consent procedures

Patients (exclusion):

  • People who cannot become pregnant (i.e., have had a hysterectomy or tubal ligation)

  • People who wish to become pregnant (will not qualify for pregnancy prevention counseling)

  • Have a scheduled visit with a member of the investigative team (to minimize risk of potential ascertainment bias)

  • Participants of Aim 1 cannot participate in Aim 2.

Sexual and Reproductive Health clinicians will be included if they provide sexual and reproductive health patient care at any of the participating sites. Clinic staff will be included if they work at any of the participating sites and have patient-facing or non-patient-facing roles .

Study Design

Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Generic Information
Phase:
Study Start date:
March 11, 2026
Estimated Completion Date:
September 05, 2027

Study Description

The purpose of this study is to expand and enhance a PrEP decision aid to include the full array of available formulation options and then integrate its delivery into sexual and reproductive health settings during counseling visits, where PrEP can be provided to all women who are interested. Rooted in health implementation frameworks, this study evaluates health and implementation determinants simultaneously along: 1) innovation characteristics; 2) clinical encounter; 3) recipients; and 4) context.

In Aim 1, patients (n=15-20), clinicians (n=10), and staff (n=10) at sexual and reproductive health clinics across Greater New Haven, CT will be engaged for semi-structured interviews to expand and enhance an existing PrEP decision aid to include all available formulations and optimize its integration into sexual and reproductive health clinics. Qualitative interviews will inform infrastructure development to support PrEP delivery in sexual and reproductive health clinics.

In Aim 2 (a hybrid Type 2 effectiveness-implementation study), patients will be randomized (n=50) to receive either the PrEP decision aid or generic PrEP information prior to a clinician visit. In follow-up interviews immediately post-visit, and at Months 3 and 6, primary outcomes are clinical efficacy (PrEP initiation) and implementation (using Proctor definitions for feasibility, acceptability, penetration, and adoption) that are important for future planned scale-up.

Connect with a study center

  • Yale Clinical and Community Research

    New Haven, Connecticut 06519
    United States

    Active - Recruiting

  • Yale Clinical and Community Research

    New Haven 4839366, Connecticut 4831725 06519
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.